Canadian Association of Psychiatric Pharmacology

Canadian Association of Psychiatric Pharmacology
Name	Canadian Association of Psychiatric Pharmacology
Abbreviation	CAPP
Type	Professional association
Headquarters	Canada
Region served	Canada
Language	English, French
Leader title	President

Canadian Association of Psychiatric Pharmacology The Canadian Association of Psychiatric Pharmacology is a professional association that brings together clinicians, researchers, and educators in Toronto, Montreal, Vancouver, and other Canadian centres to advance psychiatric pharmacology through collaboration with institutions such as McGill University, University of Toronto, University of British Columbia, McMaster University, and Queen's University. The association engages with national and international organizations including Health Canada, Canadian Institutes of Health Research, Royal College of Physicians and Surgeons of Canada, American Psychiatric Association, and World Psychiatric Association to influence practice, training, and policy across settings linked to Centre for Addiction and Mental Health, Sunnybrook Health Sciences Centre, Vancouver General Hospital, and provincial health authorities.

History

Founded by psychiatrists and pharmacologists influenced by work at McGill University Health Centre, University of Toronto Faculty of Medicine, Dalhousie University, University of Calgary, and research groups at Mayo Clinic, Massachusetts General Hospital, Johns Hopkins Hospital, and Karolinska Institutet, the association emerged amid debates involving regulators like Food and Drug Administration, European Medicines Agency, Health Canada, and advocacy groups such as Mental Health Commission of Canada and Canadian Mental Health Association. Early leadership included physicians trained at Cambridge University, Oxford University, Harvard Medical School, Yale School of Medicine, and Stanford University School of Medicine and collaborated with pharmaceutical research units at Pfizer, GlaxoSmithKline, Roche, Eli Lilly and Company, and academic centres such as University of Pennsylvania School of Medicine.

Mission and Objectives

The association's mission aligns with mandates of Canadian Institutes of Health Research, World Health Organization, Royal College of Physicians and Surgeons of Canada, Canadian Psychiatric Association, and American College of Neuropsychopharmacology to promote evidence-based psychiatric pharmacology, continuing professional development, and translational research between basic science groups at Cold Spring Harbor Laboratory, Salk Institute, Max Planck Society, and clinical programs at Toronto General Hospital. Objectives emphasize links to guideline bodies like National Institute for Health and Care Excellence, Canadian Task Force on Preventive Health Care, Institute for Clinical Evaluative Sciences, and ethics panels at Trudeau Foundation and select university research ethics boards.

Membership and Governance

Membership comprises psychiatrists, pharmacologists, pharmacists, nurse practitioners, and researchers affiliated with University of Ottawa Faculty of Medicine, Université de Montréal, University of Alberta, Simon Fraser University, and international collaborators from King's College London, Imperial College London, University of Melbourne, University of Sydney, and Seoul National University. Governance follows bylaws modeled on frameworks from Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, American Medical Association, and nonprofit statutes in Ontario and British Columbia, with elected councils including representatives linked to Canadian Pharmacists Association and provincial colleges such as College of Physicians and Surgeons of Ontario.

Activities and Programs

Programs include clinical guideline development in partnership with Canadian Network for Mood and Anxiety Treatments, quality improvement collaboratives with Institute for Healthcare Improvement, residency curriculum modules for programs at McMaster University Medical School, fellowship offerings akin to training at Massachusetts General Hospital Department of Psychiatry, and accreditation activities comparable to those of Royal College of Physicians and Surgeons of Canada and Accreditation Council for Graduate Medical Education. Initiatives also tie to public education campaigns similar to efforts by Canadian Mental Health Association, Mood Disorders Society of Canada, Schizophrenia Society of Canada, and patient advocacy groups such as Right to Play-style community programs.

Research and Publications

The association supports multicentre trials modeled after collaborations seen between NIMH, CIHR, Wellcome Trust, and consortia like ENIGMA and CATIE, and publishes position statements and systematic reviews comparable to output from Cochrane Collaboration, Lancet Psychiatry, JAMA Psychiatry, British Journal of Psychiatry, and Canadian Medical Association Journal. Research themes include psychopharmacology for mood disorders studied at Centre for Addiction and Mental Health, neuroimaging collaborations with Rotman Research Institute, pharmacogenomics work linked to Broad Institute, and translational studies involving partners at Cold Spring Harbor Laboratory and Salk Institute.

Conferences and Education

Annual scientific meetings emulate formats used by American Psychiatric Association Annual Meeting, European College of Neuropsychopharmacology Congress, World Congress of Psychiatry, and regional symposia hosted in cities like Toronto, Montreal, Calgary, Halifax, and Winnipeg. Educational offerings include continuing medical education accredited by Royal College of Physicians and Surgeons of Canada, workshops similar to those at Harvard Medical School, webinar series with speakers from Stanford University School of Medicine, and joint sessions with organizations such as Canadian Psychiatric Association, Canadian Pharmacists Association, and Canadian Nurses Association.

Partnerships and Advocacy

Advocacy efforts coordinate with Mental Health Commission of Canada, Canadian Mental Health Association, Schizophrenia Society of Canada, Centre for Addiction and Mental Health, Health Canada, and international advocacy networks including World Health Organization and United Nations initiatives to influence drug policy, access to medications, pharmacare debates involving Pharmacare Task Force, and guidelines from National Institute for Health and Care Excellence. Partnerships extend to academic centres like McGill University, industry partners comparable to GlaxoSmithKline and Eli Lilly and Company, and research funders such as Canadian Institutes of Health Research, Wellcome Trust, and Gates Foundation.

Category:Medical associations based in Canada